OARSI 2016: Bioactive collagen peptides potentially improve joint pain vs. placebo .
Efficacy of specific bioactive collagen peptides in the treatment of joint pain
The efficacy of bioactive collagen peptides (BCP) in comparison to a placebo was investigated in two randomized trials. Study 1 involved 160 athletes with activity-related knee pain and study 2 consisted of 182 patients with knee or hip pain with a mean age of 50. The studies were conducted in order to determine if pain and mobility were improved with the BCP treatment and whether BCPs have the potential to serve as a preventative treatment in the development of joint disease. In the first study, athletes treated with BCP reported significantly reduced activity-related pain in comparison to placebo. In the second study, patients treated with BCP displayed significantly reduced pain at rest and activity in comparison to a placebo group. The placebo groups in both studies experienced a large placebo effect. Further trials are needed to determine if BCP has a preventative effect on the development and progression of joint diseases.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
